Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration.

Molecular therapy. Advances·2026
Same author

Clinical Spectrum and Genetics of Ocular Manifestations in Muscle Eye Brain Disease: A Literature Review.

Seminars in ophthalmology·2026
Same author

Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials.

American journal of ophthalmology·2026
Same author

Efficacy of anti-VEGF single-chain variable fragment AAV-based gene therapy in a laser-induced choroidal neovascularisation mouse model.

Molecular therapy. Advances·2026
Same author

Optogenetics for therapeutic use in the brain, eye, and ear.

Handbook of clinical neurology·2026
Same author

Centripetal Retinal Degeneration Follows an Exponential Decay and May Be Reversed Following Gene Therapy.

American journal of ophthalmology·2026

Related Experiment Video

Updated: Feb 17, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.2K

Vector Shedding and Immunogenicity Sampling for Retinal Gene Therapy.

Alun R Barnard1,2,3, Anna N Rudenko4,5, Robert E MacLaren4,6,5,7

  • 1Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK. enquiries@eye.ox.ac.uk.

Methods in Molecular Biology (Clifton, N.J.)
|December 1, 2017
PubMed
Summary

Standardized methods are needed for collecting, processing, and storing biological samples in retinal gene therapy clinical trials. This ensures accurate assessment of vector safety and immune responses.

Keywords:
AAVClinical trialsGene therapyImmunogenicityViral vector shedding

More Related Videos

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

34.3K
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.9K

Related Experiment Videos

Last Updated: Feb 17, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.2K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

34.3K
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.9K

Area of Science:

  • Ophthalmology
  • Gene Therapy
  • Clinical Trials

Background:

  • Increasing number and scale of clinical trials for retinal gene therapy.
  • Regulatory requirements necessitate robust safety assessments.
  • Need for better understanding of vector safety profiles.

Purpose of the Study:

  • Establish standardized methods for biological sample handling in retinal gene therapy trials.
  • Facilitate assessment of vector dissemination in bodily fluids.
  • Enable evaluation of systemic cellular and humoral immune responses.

Main Methods:

  • Development of standardized protocols for sample collection.
  • Implementation of standardized processing techniques.
  • Establishment of standardized storage procedures.

Main Results:

  • Validated methods for sample collection, processing, and storage.
  • Demonstrated utility of samples for vector dissemination analysis.
  • Confirmed suitability of samples for immune response assessment.

Conclusions:

  • Standardized biological sample management is crucial for retinal gene therapy clinical trials.
  • These methods support regulatory compliance and enhance vector safety evaluation.
  • Standardized approaches are essential for monitoring patient responses.